Adalimumab plus methotrexate improved SF-36 scores and reduced the effect of rheumatoid arthritis (RA) on work activity for patients with early RA. (Q53165224)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adalimumab plus methotrexate improved SF-36 scores and reduced the effect of rheumatoid arthritis (RA) on work activity for patients with early RA. |
scientific article |
Statements
Adalimumab plus methotrexate improved SF-36 scores and reduced the effect of rheumatoid arthritis (RA) on work activity for patients with early RA. (English)
1 reference
Miriam Kimel
1 reference
Mary Cifaldi
1 reference
Naijun Chen
1 reference
Dennis Revicki
1 reference
15 December 2007
1 reference
35
1 reference
206-215
1 reference
2
1 reference
Identifiers
1 reference